IPO

Safex Chemicals (India) Ltd

Registered Office : 4&5 Flr Block A NDM 1,Netaji Subash Place North West,Delhi Delhi 110034 Phone : +91 11 6610 5000
Fax :

Email : cs@safexchemicals.com

Website : www.safexchemicals.com

Initial public offering of up to [*] equity shares of face value of Re. 1/- each ("Equity Shares") of Safex Chemicals (India) Limited ( "Company") for cash at a price of Rs.[*] per equity share (including a Share Premium of Rs.[*] per equity share) ("Offer Price") aggregating up to Rs.[*] crores, comprising a fresh issue of up to [*] equity shares of face value of Re.1/- each aggregating up to Rs. 450.00 crores by the company ("Fresh Issue") and an offer for sale of up to 35,734,818 equity shares of face value of Re.1/- each aggregating up to Rs. [*] crores by the selling shareholders, consisting of up to 1,151,088 equity shares of face value of Re. 1/- each aggregating up to Rs.[*] crores by Surinder Kumar Chaudhary, up to 748,198 equity shares of face value of Re. 1/- each aggregating up to Rs.[*] crores by Rajesh Kumar Jindal, up to 499,098 equity shares of face value of Re.1/- each aggregating up to Rs.[*] crores by Neeraj Kumar Jindal, up to 499,098 equity shares of face value of Re.1/- each aggregating up to Rs.[*] crores by Piyush Jindal (Collectively, the "Promoter Selling Shareholders"), up to 29,105,996 equity shares of face value of Re.1/- each aggregating up to Rs.[*] crores by sarcoline limited, up to 1,088,234 equity shares of face value of Rs.1/- each aggregating up to Rs.[*] crores by Anchor Partners, up to 605,770 equity shares of face value of Re.1/- each aggregating up to Rs.[*] crores by Sage Investment Trust (Collectively, the "Investor Selling Shareholders"), up to 100,000 equity shares of face value of Re.1/- each aggregating up to Rs.[*] crores by Rachna Chaudhary, up to 264,000 equity shares of face value of Re.1/- each aggregating up to Rs.[*] crores by Garima Chaudhary, up to 125,900 equity shares of face value of Re.1/- each aggregating up to Rs.[*] crores by Kiran Jindal, up to 250,000 equity shares of face value of Re.1/- each aggregating up to Rs.[*] crores by Ishan Jindal, up to 250,000 equity shares of face value of Re.1/- each aggregating up to Rs.[*] crores by Veena Jindal, up to 500,000 equity shares of face value of Re.1/- each aggregating up to Rs.[*] crores by Nivedita Jindal, up to 500,000 equity shares of face value of Re.1/- each aggregating up to Rs.[*] crores by Karishma Jindal and up to 47,436 equity shares of face value of Re.1/- each aggregating up to Rs.[*] crores by Raghunathan Hariharan ("Collectively the "Other Selling Shareholders") (the Promoter Selling Shareholders, the investor selling shareholders and other selling shareholders are collectively referred to as the "Selling Shareholders", such equity shares offered by the selling shareholders, the "offered shares" and such "Offer for Sale" and together with the fresh issue, the "Offer"). This offer includes a reservation of up to [*] equity shares of face value Re.1/- each, aggregating to Rs.[*] crores (constituting up to [*]% of the post-offer paid-up equity Share Capital of the company) for subscription by eligible employees (the "Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer shall constitute [*]% and [*]%, respectively, of the post-offer paid-up equity share capital of the company. The company, in consultation with the book running lead managers, may consider a further issue of specified securities for an amount up to Rs.90.00 crores, prior to filing of the pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the book running lead managers. if the pre-ipo placement is completed, the amount raised pursuant to the pre-ipo placement will be reduced from the fresh issue, subject to compliance with Rule 19(2)(b) of the scrr. The pre-ipo placement, if undertaken, shall not exceed 20% of the size of the fresh issue. Prior to the completion of the offer, the company shall appropriately intimate the subscribers to the pre-ipo placement, prior to allotment pursuant to the pre-ipo placement, that there is no guarantee that the company may proceed with the offer, or the offer may be successful and will result into listing of the equity shares on the stock exchanges. The proceeds of the pre-ipo placement, if undertaken, will be adjusted towards the general corporate purposes portion of the objects of the offer, unless auditor certified disclosures are made with regards to its utilization towards the disclosed specific objects of the offer. Further, relevant disclosures in relation to such intimation to the subscribers to the pre-ipo placement (if undertaken). The face value of equity shares is Re.1/- each. The offer price is [*] times the face value of the equity shares. The price band, and the minimum bid lot shall be decided by the company.